Zurcher Kantonalbank (Zurich Cantonalbank) Veru Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	BUY	$4.78 - $15.01 $2,834 - $8,900	593 Added 6.62%	9,551 $50,000
Q2 2022 Aug 09, 2022	SELL	$4.35 - $15.85 $19,688 - $71,737	-4,526 Reduced 33.57%	8,958 $101,000
Q4 2021 Feb 01, 2022	BUY	$5.89 - $9.73 $39,021 - $64,461	6,625 Added 96.59%	13,484 $79,000
Q3 2021 Nov 15, 2021	BUY	$6.78 - $9.89 $46,504 - $67,835	6,859 New	6,859 $59,000

Others Institutions Holding VERU

# of Institutions

122

Shares Held

56.8M

Call Options Held

668K

Put Options Held

531K

Adage Capital Partners Gp, L.L.C. Boston, MA

7.86M
Shares

$4.56 Million
0.01% of portfolio
Black Rock Inc. New York, NY

7.65M
Shares

$4.44 Million
0.0% of portfolio
Perceptive Advisors LLC New York, NY

7.28M
Shares

$4.22 Million
0.15% of portfolio
Vanguard Group Inc Valley Forge, PA

6.2M
Shares

$3.6 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

5.55M
Shares

$3.22 Million
0.0% of portfolio

View Full List

About VERU INC.

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $46.5M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

More about VERU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account